Preliminary report on the effect of a new derivative of acetyl salicylic acid on tissue-algogen component due to damaging stimulation of cutis

  • L. Vecchiet
  • O. Pontano
  • G. Obletter
  • L. Carratelli
Part of the Inflammation: Mechanisms and Treatment book series (FTIN, volume 4)


A derivative of acetyl salicylic acid recently synthesized, acid 5-(2,4-difluorenil)-salicylate (diflunisal), seems to be endowed with an elevated anti-phlogistic and analgesic activity1–4.


Acetyl Salicylic Acid Burning Pain Cutaneous Test Secondary Hyperalgesia Arteriolar Vasodilatation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hannah, J., Ruyle, W.V., Kelly, K., Matzuk, A. R., Holtz, W.J., Witzel, B.E., Winter, C.A., Silber, C. A. and Shen, T.Y. (1970). Flufenisal, a novel salicylate. Joint Conf. Chem. Inst. Can. Am. Chem. Soc., 18 Google Scholar
  2. 2.
    Shen, T. Y. (1972). Perspectives in non-steroidal anti inflammatory agents. Agnew. Chem. II, 460Google Scholar
  3. 3.
    Patrono, C., Ciabattoni, G., Grego, F. and Grossi Belloni, D. (1976). Comparative evaluation of the inhibitory effects of aspirin-like drugs on prostaglandin production by human platelets and synovial tissue. In Samuelsson, B. and Paoletti, R. (eds.) Advances in Prostaglandin and Thromboxane Research, p. 125Google Scholar
  4. 4.
    Tempero, K. F., Cirillo, V.J. and Steelman, S. L. (1977). Diflunisal: a review of the pharmacokinetic and pharmacodynamic properties, drug interaction and special tolerability studies in humans. Br. J. Clin. Pharmacol., 4, 31SGoogle Scholar
  5. 5.
    Galletti, R., Marra, N. and Vecchiet, L. (1960). Studio analitico dei fenomeni reattivi cutanei conseguenti a stimolazione con neve carbonica in soggetti normali. Estratto da “Lo Sperimentale”Google Scholar
  6. 6.
    Lewis, T. (1942). Pain. (New York: Macmillan)Google Scholar
  7. 7.
    Lunedei, A. (1948). Relazione 49 Cong. Soc. It. Med. Int., Pozzi, L. (ed.) RomaGoogle Scholar
  8. 8.
    Arcangeli, P. and Galletti, R. (1974). Endogenous pain producing substances. In Bonica, J. J., Procacci, P. and Pagni, C. A. (eds.) Recent advances in pain. (Springfield C.C. Thomas)Google Scholar
  9. 9.
    Vecchiet, L., Matassi, L., Buzzelli, G., Fini, F. and Branzi, G. C. (1968). Rilievisull’attività tissulo-algogena del plasma dopo la voro muscolare. La Set. Medica, 56, 823Google Scholar
  10. 10.
    Keele, C.A. and Armstrong, D. (1964). Substances producing pain and itch. (London: Arnold)Google Scholar
  11. 11.
    Vecchiet, L., Galletti, R., Matassi, L., Chiarini, P. and Buzzelli, G. (1973). Il ruolo del kininogeno nella riattivazione della flogosi sperimentale da cantaridina. Clin. Ter., 67, 339Google Scholar
  12. 12.
    Vecchiet, L., Galletti, R., Chiarini, P. and Fabrizi, L. (1973). Rapporti tra dolore ed aumento della permeabilità dei microvasi nel quadro della flogosi sperimentale da cantaridina. Clin. Ter., 667, 521Google Scholar
  13. 13.
    Roth, G. J., Stanford, N. and Majerus, P. W. (1975). Acetylation of prostaglandin-synthetase by aspirin. Proc. Natl. Acad. Sci (USA)., 72, 3073CrossRefGoogle Scholar
  14. 14.
    Majerus, P. W. and Stanford, N. (1977). Comparative effects of aspirin and diflunisal on prostaglandin-synthetase from human platelets and sheep seminal vesicles. Br. J. Clin. Pharmacol., 4, 15SPubMedGoogle Scholar

Copyright information

© MTP Press Limited 1980

Authors and Affiliations

  • L. Vecchiet
    • 1
  • O. Pontano
    • 1
  • G. Obletter
    • 1
  • L. Carratelli
    • 1
  1. 1.Italy

Personalised recommendations